Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Sep 13, 2024
Date Accepted: Apr 3, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Effectiveness of self-training with a web-based digital health application vs. physiotherapy in the treatment of disorders of the patella: a randomized controlled trial
ABSTRACT
Background:
Disorders of the patella are among the most prevalent knee injuries. While exercise therapy is widely accepted as an effective treatment strategy, the positive effects of conventional exercise therapy under the guidance of a physiotherapist may be offset by inherent limitations such as difficulties in scheduling appointments or statuary policies restricting the number of training sessions. Home-based exercise interventions using digital health applications (DHA) may help address some of these limitations.
Objective:
The aim of this study was to assess the efficacy of a 12-week exercise intervention utilizing a web-based DHA (Mawendo, Biberach, Germany) for improving knee function and/or reducing pain in patients with disorders of the patella (ICD-10 M22).
Methods:
The outcomes of the DHA intervention group (IG DHA) were compared to a control group that received conventional physiotherapy covered by statutory health insurance in Germany (CG SHI-PT). A total of 259 patients with diagnosed disorders of the patella were included in the trial and randomly allocated to IG DHA (n=136) and CG SHI-PT (n=123). The trial was registered with the DRKS (German Clinical Trials Register; WHO Primary Register) under No. DRKS00023454. Two primary endpoints were examined: 1) ‘Knee function’ (KOOSADL subscale, range 0-100 points (p)) 2) ‘Knee pain’ (visual analogue scale, VAS, range 0-100 p) Participants were asked to complete two surveys; one before the first therapy session (PRE) and one after completing the treatment period of 12 weeks (POST).
Results:
Training with the DHA resulted in a 4.5-fold greater improvement in ‘knee function’ (PRE-POST differences in KOOSADL Score; IG DHA: 15.7 p (95 % CI [13.7; 17.6]) vs. CG SHI-PT: 3.5 p (95 % CI [1.5; 5.5])) and a 3.5-fold greater reduction in ‘knee pain’ (PRE-POST differences in VAS pain score; IG DHA: -22.5 p (95 % CI [-25.2; -19.9]) vs. CG SHI-PT: -6.5 p (95 % CI [-8.7; -4.4])) compared to SHI-PT. Only the improvements in IG DHA exceeded the limits of clinical relevance. The differences between the treatment groups (KOOSADL score -10.1 p (95 % CI [Inf; -8.0]), VAS pain score 14.3 p (95 % CI [11.7; Inf])) were statistically significant (P < .001) for both endpoints in favor of IG DHA. No effect was found for age or sex. The reported use of pain medication decreased substantially in IG DHA, and showed almost no change in CG SHI-PT.
Conclusions:
Our findings indicate that the investigated DHA is superior to SHI-PT for treating disorders of the patella. DHA has therefore been approved by the German Federal Institute for Drugs and Medical Devices for the treatment of disorders of the patella in persons of all sexes aged 12 and over. Clinical Trial: The trial was registered with the DRKS (German Clinical Trials Register; WHO Primary Register; https://drks.de/search/de) under No. DRKS00023454.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.